- Report
- July 2025
- 214 Pages
Global
From €5303EUR$5,850USD£4,588GBP
- Report
- July 2025
- 375 Pages
Global
From €5303EUR$5,850USD£4,588GBP
- Report
- August 2025
- 303 Pages
Global
From €5303EUR$5,850USD£4,588GBP
- Report
- March 2025
- 300 Pages
Global
From €4070EUR$4,490USD£3,521GBP
- Report
- February 2025
- 200 Pages
Global
From €4070EUR$4,490USD£3,521GBP
- Report
- January 2025
- 175 Pages
Global
From €4070EUR$4,490USD£3,521GBP
- Report
- July 2025
- 173 Pages
Global
From €5303EUR$5,850USD£4,588GBP
- Report
- July 2025
- 191 Pages
Global
From €5303EUR$5,850USD£4,588GBP
- Report
- August 2025
- 183 Pages
Global
From €5303EUR$5,850USD£4,588GBP
- Report
- August 2025
- 486 Pages
Global
From €5303EUR$5,850USD£4,588GBP
- Report
- April 2025
- 175 Pages
Global
From €4070EUR$4,490USD£3,521GBP
- Report
- April 2025
- 200 Pages
Global
From €4070EUR$4,490USD£3,521GBP
- Report
- March 2025
- 200 Pages
Global
From €4070EUR$4,490USD£3,521GBP
- Report
- March 2025
- 200 Pages
Global
From €4070EUR$4,490USD£3,521GBP
- Report
- February 2025
- 200 Pages
Global
From €4070EUR$4,490USD£3,521GBP
- Report
- May 2025
- 188 Pages
Global
From €4080EUR$4,500USD£3,529GBP
- Report
- February 2025
- 182 Pages
Global
From €4080EUR$4,500USD£3,529GBP
- Report
- February 2025
- 188 Pages
Global
From €4080EUR$4,500USD£3,529GBP
- Report
- November 2024
- 140 Pages
Global
From €4034EUR$4,450USD£3,490GBP
- Report
- January 2025
- 140 Pages
Global
From €3581EUR$3,950USD£3,098GBP

The Drug Discovery AI market is a rapidly growing sector of the pharmaceutical industry, focused on the development of artificial intelligence (AI) technologies to aid in the discovery of new drugs. AI-driven drug discovery is a process that uses machine learning algorithms to identify potential drug targets and develop new drug candidates. AI-driven drug discovery can reduce the time and cost of drug development, as well as improve the accuracy of drug discovery.
The Drug Discovery AI market is composed of a variety of companies, ranging from large pharmaceutical companies to small startups. Companies in the market include Atomwise, Exscientia, Insilico Medicine, and Recursion Pharmaceuticals. These companies are developing AI-driven drug discovery technologies to help accelerate the drug discovery process. Show Less Read more